Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium

被引:0
|
作者
AI Catrina
S Ernestam
E af Klint
L Klareskog
AK Ulfgren
机构
[1] Karolinska Institutet/Hospital,Rheumatology Department
[2] Huddinge Hospital,Rheumatology Department
来源
关键词
Rheumatoid Arthritis; Tumour Necrosis Factor; Infliximab; Etanercept; Active Rheumatoid Arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
    Catrina, AI
    Ernestam, S
    Klint, EA
    Klareskog, L
    Ulfgren, AK
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 1) : S9 - S9
  • [2] Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis
    Gonzalez-Gay, M. A.
    Garcia-Unzueta, M. T.
    Berja, A.
    Vazquez-Rodriguez, T. R.
    Gonzalez-Juanatey, C.
    de Matias, J. M.
    Martin, J.
    Dessein, P. H.
    Llorca, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) : 1644 - 1646
  • [3] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [4] Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
    Leandro, Maria J.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (05)
  • [5] Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
    Hyrich, KL
    Silman, AJ
    Watson, KD
    Symmons, DPM
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1538 - 1543
  • [6] Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium
    Catrina, A. I.
    Makrygiannakis, D.
    af Klint, E.
    Catrina, S. B.
    Ernestam, S.
    Klareskog, L.
    Ulfgren, A. K.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S31 - S32
  • [7] Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
    Maria J Leandro
    Arthritis Research & Therapy, 11
  • [8] Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium
    AI Catrina
    D Makrygiannakis
    E af Klint
    SB Catrina
    S Ernestam
    L Klareskog
    AK Ulfgren
    Arthritis Research & Therapy, 7
  • [9] Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Madhok, Rajan
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1571 - 1571
  • [10] Salmonella enterica Arthritis in a Patient with Rheumatoid Arthritis Receiving Anti-tumour Necrosis Factor Therapy
    Bubonja-Sonje, M.
    Rubinic, D.
    Anic, F.
    Novak, S.
    Vuckovic, D.
    Abram, M.
    WEST INDIAN MEDICAL JOURNAL, 2013, 62 (03): : 270 - 272